MONTREAL, Sept. 15, 2011 /CNW Telbec/ - Noveko International Inc. (TSX:
EKO) (the "Company") is pleased to announce that its subsidiary Noveko
Inc. ("Noveko") has obtained an order worth $240,000 by
Dufort & Lavigne Ltd. ("Dufort & Lavigne"), a Quebec business
specializing in the distribution of medical supplies and equipment.
This order is scheduled to be delivered within a few days. As
distributor of the Company's products, Dufort & Lavigne will primarily
ensure the Quebec-wide sale and promotion of Microban® hand sanitizers
to medical and dental clinics as well as of Noveko™ antimicrobial masks
to medical clinics and hospital centres.
"We are pleased we can now count on the expertise of Dufort & Lavigne.
Its solid sales team and the size of its Quebec network will provide us
with foremost access to healthcare niches in which we had little
presence up to now. This initial collaboration fits with our strategy
of partnering with leaders in their respective markets to stimulate the
commercialization of our products," indicated Mr. Alain Bolduc,
President and Chief Operating Officer of the Company.
"We selected Noveko as a supplier in order to expand our offering of
value-added products and better serve the needs of our healthcare
clients. Due to the innovative characteristics of Noveko's products,
including their particularly useful antimicrobial properties in
preventing the spread of germs, we are confident we will provide our
specialized clients with new superior and effective solutions," added
Mr. Yves Dufort, President of Dufort & Lavigne.
Founded in 1962, Dufort & Lavigne is a Quebec-wide business specializing
in the distribution of medical supplies and equipment. More than 100
employees work primarily at the Montreal head office, and at its branch
office located in Quebec City. Its sales force of 15 representatives
and its 17 customer service employees ensure its presence throughout
Quebec so as to meet the various needs of the medical, paramedical,
dental, ambulance and other fields.
Noveko International Inc. offers innovative solutions in the
environmental and medical fields worldwide. Through its subsidiaries,
the Company specializes primarily in the following business segments:
the development, manufacturing and marketing of derivative products
from its patented antimicrobial filtration technologies, mainly air
filters, surgical masks and respirators, as well as other products with
antibacterial properties such as hand sanitizers - and the development,
manufacturing and marketing of medical equipment, including portable
real-time ultrasound scanners for use in human and veterinary medicine.
Certain statements set forth in this press release constitute
forward-looking statements. In some cases, these statements are
identified by the use of terms such as "may", "could", "might",
"intend", "should", "expect", "project", "plan", "believe", "estimate"
or other comparable variants. These statements are based on the
information available at the time they are written, on assumptions made
by management and on the expectations of management, acting in good
faith, regarding future events, including those relating to economic
conditions, fluctuations in exchange rates and operating expenses, and
the absence of unusual events entailing supplementary expenditures.
Although management considers these assumptions and expectations
reasonable based on the information available at the time they are
written, they could prove inaccurate. Forward-looking statements are
also subject, by their very nature, to known and unknown risks and
uncertainties such as those related to the industry, acquisitions,
labor relations, credit, key officers, supply and product liability.
The actual results of Noveko International Inc. could differ materially
from those indicated or underlying these forward-looking statements.
The reader is therefore recommended not to unduly rely on these
forward-looking statements. Forward-looking statements do not reflect
the potential impact of special items, any business combination or any
other transaction that may be announced or occur subsequent to the date
hereof. Unless otherwise required under securities laws, the Company
does not intend and undertakes no obligation to update or revise the
forward-looking statements to reflect new information, new events or
SOURCE NOVEKO INTERNATIONAL INC.
For further information:
Chantal Vennat, Director,
Investor Relations and Corporate Communications
Noveko International Inc.
Tel: (514) 875-0606